Poster Abstracts

Total Page:16

File Type:pdf, Size:1020Kb

Poster Abstracts Drug Metabolism Reviews ISSN: 0360-2532 (Print) 1097-9883 (Online) Journal homepage: http://www.tandfonline.com/loi/idmr20 Poster Abstracts To cite this article: (2011) Poster Abstracts, Drug Metabolism Reviews, 43:sup2, 37-211, DOI: 10.3109/03602532.2011.629832 To link to this article: http://dx.doi.org/10.3109/03602532.2011.629832 Published online: 07 Nov 2011. Submit your article to this journal Article views: 2899 View related articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=idmr20 Download by: [176.12.237.34] Date: 26 January 2017, At: 12:03 Drug Metabolism Reviews Drug Metabolism Reviews, 2011; 43(S2): 37–211 2011 © 2011 Informa Healthcare USA, Inc. ISSN 0360-2532 print/ISSN 1097-9883 online 43 DOI: 10.3109/03602532.2011.629832 S2 37 Poster Abstracts 211 00 00 0000 P1. A method for monitoring drug exposure in hematopoietic stem cell transplant recipients 00 00 0000 Isabelle Laverdiere1, Patrick Caron2, Félix Couture3, Éric Lévesque4 and Chantal Guillemette5 00 00 0000 1Laval University, CHUL Research Center, Quebec, QC, Canada, 2CHUL Research Center, Quebec, QC, Canada, 0360-2532 3Hematology-oncology, Hôtel-Dieu de Québec Hospital, Québec, QC, Canada, 4Pharmacogenomics Laboratory, CHUQ Research Center, Québec, QC, Canada, 5Pharmacogenomics Laboratory, CHUQ Research Center and Faculty of 1097-9883 Pharmacy, Laval University, Québec, QC, Canada © 2011 Informa Healthcare USA, Inc. The use of combinations of immunosuppressant drugs is considered the therapeutic gold standard for post-allogeneic hematopoietic stem cell transplantation (HSCT) to prevent serious complications such as graft versus host disease and rejec- 10.3109/03602532.2011.629832 tion. However, these drugs have a narrow therapeutic index and wide inter-individual pharmacokinetic fluctuations, result- ing in unpredictable levels of drugs in the blood. Systemic concentrations of several immunosuppressive drugs have been correlated with their efficacy and potential life-threatening complications, thus supporting the need for a pharmacokinetic monitoring. Some chromatographic techniques have been proposed for the simultaneous monitoring of multiple immuno- suppressive drugs, but none offers the possibility of measuring cyclosporine, tacrolimus, methotrexate, prednisone, pred- nisolone, and methylprednisone in addition to total and free mycophenolic acid (MPA) and its phenolic (MPAG) and acyl (AcMPAG) glucuronides. To address this critical deficiency, a liquid chromatography–coupled tandem mass spectrometry method was developed for the quantification of circulating levels of these multiple immunosuppressant drugs. Linearity, pre- cision and accuracy were validated within the typical therapeutic range of concentrations for each compound. The method could measure individual drugs with high sensitivity, accuracy (bias <14%), and reproducibility (CV <12.8%). Its clinical appli- cation was validated by measuring levels of these drugs in samples obtained from HSCT recipients treated with combined immunosuppressive drug therapy. Our results indicate that this approach is suitable for simultaneous determination of in vivo levels of immunosuppressive drugs commonly used in combined therapies. This method requires a small-volume peripheral blood sample, an attribute that may be beneficial to HSCT patients in the clinic. Indeed, owing to the frequent administration of myeloablative conditioning regimens in the pre-transplantation period, the recovery of hematologic function is slow and gradual after engraftment. It is therefore favorable to limit blood sample collection in the immediate post-transplantation period. This method may be convenient for large-scale clinical studies aimed at improving and optimizing patient outcomes. It could also be useful in therapeutic drug monitoring to promote the efficient use of immunosuppressive drugs and thus to limit life-threatening complications related to non-optimal exposure to immunosuppressive medications. P2. Abstract withdrawn P3. Absolute UGT protein quantification by LC-MS3 Richard King1, Carmen Fernandez-Metzler1 and J. Larry Campbell2 1PharmaCadence Analytical Services, LLC, Hatfield, PA, 2AB SCIEX, Concord, ON, Canada The absolute quantification of proteins involved in drug metabolism is a new area that is gaining in popularity and utility. By far the most often used strategy is the surrogate peptide approach. These methods rely on detection of peptides created from the protein of interest by enzymatic or chemical digestion. Typically, the protein of interest and a stable isotopically labeled internal standard peptide are digested in a relevant sample such as a microsomal fraction or plasma containing often large amounts of other proteins. The final digested sample may contain thousands of peptides derived from any combination of the proteins present in the sample matrix. The complexity of the digested sample makes selective detection a challenge, even 37 38 Poster Abstracts by LC-MS/MS. Selected reaction monitoring (SRM) of HPLC separated samples is most often considered the gold standard for selectivity; however, SRM often does not have the selectivity needed to allow absolute quantification of surrogate peptides from biological matrices. Vastly improved selectivity can be realized using MS3. MS3 is a term used to describe multiple steps of mass dependent isolation and fragmentation followed by mass analysis and detection. The extra step of isolation and fragmentation associated with MS3 provides the enhanced selectivity of the technique. In this presentation, we discuss the implementation of MS3 with 40ms cycle time on the 5500QTRAP and we compare the quantitative results for six UGT isoforms measured from human liver microsomes using selected reaction monitoring and MS3. The work was done using the ABSciex QTRAP 5500 mass spectrometer and an Eksigent HT Express HPLC with 1.0 mm ID × 30 mm C18 reverse phase column and gradient elution. The enhanced selectivity of MS3 improves assay precision as measured by %CV and the assay LLOQ as compared to SRM. The improvement in signal to noise also makes automated data processing of the MS3 data for quantitative analysis of protein practical. The time required to integrate the MS3 mass chromatograms and provide quantita- tive results is approximately 30% of the time required to process the SRM data for the same samples. P4. Application of the narrow window mass extraction technique for in vitro adme screening in drug discovery Barry Press, Rima Al-Awar and Ahmed Aman Medicinal Chemistry, Ontario Institute for Cancer Research, Toronto, ON, Canada Incorporating higher throughput analytical methods and enhancing the ability for data mining of in vitro ADME samples can greatly benefit drug discovery teams during lead optimization. Standard bioanalytical techniques generally rely on triple quadrupole mass spectrometers using the technique of multiple reaction monitoring (MRM) for quantification (QUAN). Although this conventional MRM approach can provide high specificity and sensitivity, this practice is also time-consuming since it is a two-step process and requires the optimization of multiple parameters (cone voltage, colli- sion energy, and Q1/Q3 m/z values) for each and every compound being analyzed. Furthermore, MRM techniques only detect the initial compound of interest and data mining for other, qualitative (QUAL) information (such as metabolite formation) is not possible. The use of a sensitive hybrid Q-Tof instrument in a full scan acquisition mode and subse- quent narrow window mass eliminates the need for compound optimization while also providing both qualitative and quantitative (QUAL/QUAN) data to assist chemistry efforts in structure-property-relationships (SPR). The Xevo-Q-TOF mass spectrometer is a high resolution accurate mass instrument which possesses the speed, sensitivity, linearity, and wide mass range needed to screen in vitro ADME samples. The high resolution capabilities of Q-TOF-MS, combined with mass defect filtering and monitoring of isotopic peak patterns, allows for the discrimination against background noise when performing narrow window mass extraction from a full scan analysis. Samples were generated from multiple ADME assays including cellular (Caco-2) permeability, microsomal and hepatocyte stability, plasma stability, protein binding, and CYP450 inhibition of (known) metabolite formation. Chromatographic separations were obtained utilizing an Acquity UPLC and generic gradient conditions. Quantitative results obtained by narrow m/z windows were com- pared with traditional MRM analysis of the same samples analyzed using the high-sensitivity QTRAP 5500 system.. Data mining was then performed on the full scan analysis to identify known metabolites such as glucuronide, de-methylated, and hydroxylated metabolites from metabolic assays, as well as to determine possible non-hepatic compound instability and isomerization from in vitro plasma stability and permeability samples. Results indicate that the use of the Xevo-Q- TOF, combined with narrow window mass extraction and full scan analysis, gives comparable quantitative data (e.g. percent loss of parent compound) to conventional MRM techniques without the need for time-consuming compound optimization of new chemical entities (NCEs) or known CYP-dependent metabolites. In addition, valuable qualitative information could be obtained only from Xevo-Q-TOF full scans showing the susceptibility of reference compounds and NCEs
Recommended publications
  • Effect of Hypercholesterolaemia on Voltage-Operated Calcium Channel Currents in Rabbit Arterial Smooth Muscle Cells
    Journal of Human Hypertension (1999) 13, 849–853 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Effect of hypercholesterolaemia on voltage-operated calcium channel currents in rabbit arterial smooth muscle cells GF Clunn, S Wijetunge and AD Hughes Clinical Pharmacology, NHLI, St. Mary’s Hospital, Imperial College of Science, Technology and Medicine, South Wharf Road, London, W2 1NY, UK Cholesterol is a major component of cell membranes capacitance was also greater in NZ cells. Consequently, and influences membrane fluidity. Watanabe heritable there was no significant difference in current density hyperpercholesterolaemic rabbits (WHHL) possess between NZ and WHHL cells either in the absence of defective receptors for low density lipoprotein leading drug or in the presence of the calcium channel agonist to increased plasma cholesterol, accumulation of chol- (+)202 791. Current voltage-relationships, kinetics of esterol in the arterial wall and atherosclerosis. In this fast inactivation and steady-state inactivation of IBa also study calcium channel currents (IBa) were compared did not differ significantly between WHHL and NZ. These using conventional whole cell voltage clamp techniques findings suggest that hypercholesterolaemia in WHHL in ear artery cells isolated from control New Zealand has no direct effect on calcium channel current density White rabbits (NZ) with those from WHHL. IBa were larger or voltage-modulation in arterial smooth muscle cells. in cells isolated from NZ than from WHHL, however cell Keywords: calcium channel; cholesterol; vascular smooth muscle; Watanabe hypercholesterolaemic rabbit Introduction atic cholesterol toxicity or other organ damage which develops in cholesterol-fed rabbits.15 WHHL Cholesterol is a major component of cell membranes 1,2 has therefore been proposed to be a model of human and influences membrane structure and fluidity.
    [Show full text]
  • Detailed Review Paper on Retinoid Pathway Signalling
    1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process.
    [Show full text]
  • Basic Quant GCMS
    Harris County Institute of Forensic Sciences Section: Toxicology Approved By: Toxicology Manager Document Type: GC & GC/MS Procedure No.: TOX07.3005 Title: Quantitation of basic drugs by gas chromatography / mass spectrometry Rev.:15 1.0 Purpose 1.1 This document describes the procedures used by the Toxicology Laboratory to quantitate basic drugs using gas chromatography/mass spectrometry. 1.2 Biological specimens are basified to the moderately alkaline pH 9 at which basic compounds are in an unionized form and are soluble in an organic solvent. After liquid/liquid extraction, the organic layer is separated and the compound X is back extracted into 2 N HCl. The acid layer is then made alkaline and compound X is re-extracted into an organic solvent. 2.0 Scope 2.1 The assay is appropriate for quantitation of any basic compound (X) in blood including serum and plasma, urine, bile, stomach contents or tissue homogenates. 3.0 Definitions and Abbreviations 3.1 No method-specific or non-standard terms are used in this procedure. 4.0 Materials 4.1 Instruments and Equipment 4.1.1 13 x 100 mm screw top tubes and caps 4.1.2 Mixer 4.1.3 Rocker 4.1.4 Centrifuge 4.1.5 Transfer pipettes 4.1.6 Autosampler vials and rubber septum caps 4.1.7 Autosampler vial inserts 4.1.8 Vial crimper 4.1.9 100uL syringe 4.1.10 GC/MS Uncontrolled4.2 Reagents Copy 4.2.1 Ammonium Hydroxide Reagent Grade 4.2.2 n-Butyl chloride (chlorobutane) HPLC Grade 4.2.3 Saturated Sodium Borate Buffer, pH 9.3 A.
    [Show full text]
  • Liarozole Hydrochloride (BANM, USAN, Rinnm) Kinetin Hidrocloruro De Liarozol; Liarozole, Chlorhydrate De; Liarozoli 1
    Isotretinoin/Liarozole 1603 Malignant neoplasms. Retinoids such as isotretinoin have 9. Matthay KK, et al. Treatment of high-risk neuroblastoma with Profile been studied in the treatment of various neoplastic or preneoplas- intensive chemotherapy, radiotherapy, autologous bone marrow Kinetin is a plant growth hormone that has been promoted in transplantation, and 13-cis-retinoic acid. N Engl J Med 1999; tic disorders. Although oral tretinoin is used for remission induc- 341: 1165–73. products for the management of photodamaged skin and hyper- tion in acute promyelocytic leukaemia (see p.1619), other retin- 10. Kohler JA, et al. A randomized trial of 13-cis retinoic acid in pigmentation but good evidence of efficacy appears to be lack- oids do not have an established role in the treatment of cancer. children with advanced neuroblastoma after high-dose therapy. ing. There may, however, be a place for the use of retinoids in the Br J Cancer 2000; 83: 1124–7. Preparations chemoprevention of some malignancies. Skin disorders. Apart from its established role in the treatment Proprietary Preparations (details are given in Part 3) There has been particular interest in the potential for retinoids to of acne (above), isotretinoin has been tried in many other skin Arg.: Kinerase†; Braz.: Kinerase; Hong Kong: Kinerase; Malaysia: Kin- prevent the formation of skin cancers (p.672) in patients at in- disorders not responding to usual therapy.1,2 Clinical responses to erase†; Mex.: Kinerase; Singapore: Kinerase; USA: Kinerase. creased risk. Maintenance immunosuppression may increase the oral isotretinoin have been reported1 in small numbers of patients incidence of pre-malignant and malignant skin lesions in solid with anogenital warts (p.1584), rosacea (p.1583), and lichen pla- organ transplant recipients; large numbers of lesions can develop nus (p.1580).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0024365A1 Vaya Et Al
    US 2006.0024.365A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0024365A1 Vaya et al. (43) Pub. Date: Feb. 2, 2006 (54) NOVEL DOSAGE FORM (30) Foreign Application Priority Data (76) Inventors: Navin Vaya, Gujarat (IN); Rajesh Aug. 5, 2002 (IN)................................. 699/MUM/2002 Singh Karan, Gujarat (IN); Sunil Aug. 5, 2002 (IN). ... 697/MUM/2002 Sadanand, Gujarat (IN); Vinod Kumar Jan. 22, 2003 (IN)................................... 80/MUM/2003 Gupta, Gujarat (IN) Jan. 22, 2003 (IN)................................... 82/MUM/2003 Correspondence Address: Publication Classification HEDMAN & COSTIGAN P.C. (51) Int. Cl. 1185 AVENUE OF THE AMERICAS A6IK 9/22 (2006.01) NEW YORK, NY 10036 (US) (52) U.S. Cl. .............................................................. 424/468 (22) Filed: May 19, 2005 A dosage form comprising of a high dose, high Solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of Related U.S. Application Data immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of (63) Continuation-in-part of application No. 10/630,446, modified release active ingredient per unit is from 500 mg to filed on Jul. 29, 2003. 1500 mg, a process for preparing the dosage form. Patent Application Publication Feb. 2, 2006 Sheet 1 of 10 US 2006/0024.365A1 FIGURE 1 FIGURE 2 FIGURE 3 Patent Application Publication Feb. 2, 2006 Sheet 2 of 10 US 2006/0024.365A1 FIGURE 4 (a) 7 FIGURE 4 (b) Patent Application Publication Feb. 2, 2006 Sheet 3 of 10 US 2006/0024.365 A1 FIGURE 5 100 ov -- 60 40 20 C 2 4.
    [Show full text]
  • Single Laboratory Validation of a Quantitative Core Shell-Based LC
    Single Laboratory Validation of a Quantitative Core Shell-Based LC Separation for the Evaluation of Silymarin Variability and Associated Antioxidant Activity of Pakistani Ecotypes of Milk Thistle (Silybum Marianum L.) Samantha Drouet, Bilal Haider Abbasi, Annie Falguieres, Waqar Ahmad, S. Sumaira, Clothilde Ferroud, Joël Doussot, Jean Vanier, Christophe Hano To cite this version: Samantha Drouet, Bilal Haider Abbasi, Annie Falguieres, Waqar Ahmad, S. Sumaira, et al.. Single Laboratory Validation of a Quantitative Core Shell-Based LC Separation for the Evaluation of Sily- marin Variability and Associated Antioxidant Activity of Pakistani Ecotypes of Milk Thistle (Silybum Marianum L.). Molecules, MDPI, 2018, 23 (4), pp.904. 10.3390/molecules23040904. hal-02538464 HAL Id: hal-02538464 https://hal.archives-ouvertes.fr/hal-02538464 Submitted on 9 Apr 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License molecules Article Single Laboratory Validation of a Quantitative Core Shell-Based
    [Show full text]
  • Silychristin Derivatives Conjugated with Coniferylalcohols from Silymarin and Their Pancreatic Α-Amylase Inhibitory Title Activity
    Silychristin derivatives conjugated with coniferylalcohols from silymarin and their pancreatic α-amylase inhibitory Title activity Author(s) Kato, Eisuke; Kushibiki, Natsuka; Satoh, Hiroshi; Kawabata, Jun Natural Product Research, 34(6), 759-765 Citation https://doi.org/10.1080/14786419.2018.1499639 Issue Date 2020-03-18 Doc URL http://hdl.handle.net/2115/80605 This is an Accepted Manuscript of an article published by Taylor & Francis in Natural Product Research on Rights Mar.18.2020, available online: http://www.tandfonline.com/10.1080/14786419.2018.1499639. Type article (author version) File Information EK_NatProdRes_milk_thistle_w_supplement.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP *Post-print manuscript This document is the unedited Author's version of a Submitted Work that was subsequently accepted for publication in “Natural Product Research” published by Taylor & Francis after peer review. To access the final edited and published work see https://doi.org/10.1080/14786419.2018.1499639 Graphical abstract 1 RESEARCH ARTICLE Silychristin derivatives conjugated with coniferylalcohols from silymarin and their pancreatic α-amylase inhibitory activity Eisuke Katoa*, Natsuka Kushibikib, Hiroshi Satohc and Jun Kawabataa aDivision of Fundamental AgriScience and Research, Research Faculty of Agriculture, Hokkaido University, Kita-ku, Sapporo, Hokkaido 060-8589, Japan bDivision of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Kita-ku, Sapporo, Hokkaido 060-8589, Japan cNissei Bio Co. Ltd., Eniwa, Hokkaido, 061-1374, Japan *Corresponding author. Eisuke Kato, 1Division of Fundamental AgriScience and Research, Research Faculty of Agriculture, Hokkaido University, Kita-ku, Sapporo, Hokkaido 060-8589, Japan; Tel/Fax: +81 11 706 2496; e-mail: [email protected] 2 Abstract Silymarin is a mixture of flavonolignans extracted from the fruit of Silybum marianum (milk thistle).
    [Show full text]
  • Progress Towards Genetic and Pharmacological Therapies for Keratin Genodermatoses: Current Perspective and Future Promise
    15 March 2005 Use of Articles in the Pachyonychia Congenita Bibliography The articles in the PC Bibliography may be restricted by copyright laws. These have been made available to you by PC Project for the exclusive use in teaching, scholar- ship or research regarding Pachyonychia Congenita. To the best of our understanding, in supplying this material to you we have followed the guidelines of Sec 107 regarding fair use of copyright materials. That section reads as follows: Sec. 107. - Limitations on exclusive rights: Fair use Notwithstanding the provisions of sections 106 and 106A, the fair use of a copyrighted work, including such use by reproduction in copies or phonorecords or by any other means specified by that section, for purposes such as criticism, comment, news reporting, teaching (including multiple copies for classroom use), scholarship, or research, is not an infringement of copyright. In determining whether the use made of a work in any particular case is a fair use the factors to be considered shall include - (1) the purpose and character of the use, including whether such use is of a commercial nature or is for nonprofit educational purposes; (2) the nature of the copyrighted work; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole; and (4) the effect of the use upon the potential market for or value of the copyrighted work. The fact that a work is unpublished shall not itself bar a finding of fair use if such finding is made upon consideration of all the above factors.
    [Show full text]
  • Robert Foti to Cite This Version
    Characterization of xenobiotic substrates and inhibitors of CYP26A1, CYP26B1 and CYP26C1 using computational modeling and in vitro analyses Robert Foti To cite this version: Robert Foti. Characterization of xenobiotic substrates and inhibitors of CYP26A1, CYP26B1 and CYP26C1 using computational modeling and in vitro analyses. Agricultural sciences. Université Nice Sophia Antipolis, 2016. English. NNT : 2016NICE4033. tel-01376678 HAL Id: tel-01376678 https://tel.archives-ouvertes.fr/tel-01376678 Submitted on 5 Oct 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Université de Nice-Sophia Antipolis Thèse pour obtenir le grade de DOCTEUR DE L’UNIVERSITE NICE SOPHIA ANTIPOLIS Spécialité : Interactions Moléculaires et Cellulaires Ecole Doctorale : Sciences de la Vie et de la Santé (SVS) Caractérisation des substrats xénobiotiques et des inhibiteurs des cytochromes CYP26A1, CYP26B1 et CYP26C1 par modélisation moléculaire et études in vitro présentée et soutenue publiquement par Robert S. Foti Le 4 Juillet 2016 Membres du jury Dr. Danièle Werck-Reichhart Rapporteur Dr. Philippe Roche Rapporteur Pr. Serge Antonczak Examinateur Dr. Philippe Breton Examinateur Pr. Philippe Diaz Examinateur Dr. Dominique Douguet Directrice de thèse 1 1. Table of Contents 1. Table of Contents ..............................................................................................................................
    [Show full text]
  • Siteand Mechanism of Action of Resin Acids on Voltage-Gated Ion Channels
    Linköping University Medical Dissertation No. 1620 Site and Mechanism of Action of Resin Acids on Voltage-Gated Ion Channels Malin Silverå Ejneby Department of Clinical and Experimental Medicine Linköping University, Sweden Linköping 2018 © Malin Silverå Ejneby, 2018 Cover illustration: “The Charged Pine Tree Anchored to the Ground” was designed and painted by Daniel Silverå Ejneby. Printed in Sweden by LiU-Tryck, Linköping, Sweden, 2018 ISSN: 0345-0082 ISBN: 978-91-7685-318-4 TABLE OF CONTENTS ABSTRACT ............................................................................................................................... 1 POPULÄRVETENSKAPLIG SAMMANFATTNING ................................................................. 3 LIST OF ARTICLES .................................................................................................................. 5 INTRODUCTION ....................................................................................................................... 7 Ions underlie the electrical activity in the heart and brain .................................................. 7 A mathematical model for the nerve impulse - Hodgkin and Huxley ............................... 7 Cardiac action potentials – a great diversity of shapes ...................................................... 9 Voltage-gated ion channels ......................................................................................................... 9 General structure ....................................................................................................................
    [Show full text]
  • Niflumic Acid Hyperpolarizes Smooth Muscle Cells Via Calcium-Activated Potassium Channel in Spiral Modiolar Artery of Guinea Pigs1
    Acta Pharmacol Sin 2008 Jul; 29 (7): 789–799 Full-length article Niflumic acid hyperpolarizes smooth muscle cells via calcium-activated potassium channel in spiral modiolar artery of guinea pigs1 Li LI2,3, Ke-tao MA3,4, Lei ZHAO3, Jun-qiang SI3,4,5, Zhong-shuang ZHANG3, He ZHU3, Jing LI3 2Departmeng of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China; 3Labo- ratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University Medical College, Xinjiang 832002, China; 4Fundamental Medical School of Wuhan University, Wuhan 430071, China Key words Abstract spiral modiolar artery; smooth muscle cells; Aim: The influence of niflumic acid (NFA), a Cl– channel antagonist, on the mem- 2+ niflumic acid; hyperpolarization; Ca - brane potentials in smooth muscle cells (SMC) of the cochlear spiral modiolar activated potassium channels; cochlea artery (SMA) in guinea pigs was examined. Methods: The intracellular recording 1This work was supported by the National and whole-cell recording technique were used to record the NFA-induced re- Natural Science Foundation of China (No sponse on the acutely-isolated SMA preparation. Results: The SMC had 2 stable 30460043); the Scientific and Technological Program for Overseas Personnel, the but mutually convertible levels of resting potentials (RP), that is, one was near –45 Ministry of Personnel, China (2006); and the mV and the other was approximately –75 mV, termed as low and high RP, Key Program of Scientific and Technological respectively. The bath application of NFA could cause a hyperpolarization in all Research, the Ministry of Education, China (Local Universities; No 207134). the low RP cells, but had little effect on high RP cells.
    [Show full text]
  • ECO Cup One Step Drug Test Forensic Insert
    paranoia, hallucinations, and psychotic behavior. The effects of Amphetamines generally last 2-4 unconsciousness. hours following use, and the drug has a half-life of 4-24 hours in the body. About 30% of Cocaine is often self-administered by nasal inhalation, intravenous injection and free-base Amphetamines are excreted in the urine in unchanged form, with the remainder as hydroxylated smoking. It is excreted in the urine in a short time primarily as Benzoylecgonine. 1.2 and deaminated derivatives. Benzoylecgonine, a major metabolite of cocaine, has a longer biological half-life (5-8 hours) than 2 The ECO CUP™ One Step Drug Test yields a positive result when the concentration of Amphetamine cocaine (0.5-1.5 hours), and can generally be detected for 24-48 hours after cocaine exposure. in urine exceeds 1,000 ng/mL. This is the suggested screening cut-off for positive specimens The ECO CUP™ One Step Drug Test yields a positive result when the concentration of Benzoylecgonine set by the Substance Abuse and Mental Health Services Administration (SAMHSA, USA).3 in urine exceeds 300 ng/mL. This is the suggested screening cut-off for positive specimens set by One Step Drug Test the Substance Abuse and Mental Health Services Administration (SAMHSA, USA). 3 Package Insert for Multi Drug Screen Test Cup AMPHETAMINE (AMP 500) COCAINE (COC 150) This Instruction Sheet is for testing of any combination of the following drugs: See AMPHETAMINE (AMP 1000) for the summary. See COCAINE (COC 300) for the summary. AMP/BAR/BZO/BUP/COC/THC/MTD/mAMP/MDMA/MOR/OPI/OXY/PCP/PPX/TCA/EDDP/6-ACM/ETG The ECO CUP™ One Step Drug Test yields a positive result when the concentration of The ECO CUP™ One Step Drug Test yields a positive result when the concentration of Including Adulterant Tests (Specimen Validity Tests) for: Amphetamine in urine exceeds 500 ng/mL.
    [Show full text]